The tick saliva peptide HIDfsin2 promotes the tick-borne virus SFTSV replication in vitro by enhancing p38 signal pathway.

Authors:
Wang L; Sun F; Hu J; Zuo W; Zheng Y and 3 more

Journal:
Arch Toxicol

Publication Year: 2023

DOI:
10.1007/s00204-023-03515-2

PMCID:
PMC10163292

PMID:
37148319

Journal Information

Full Title: Arch Toxicol

Abbreviation: Arch Toxicol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Toxicology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestThe authors declare no competing financial interest. Conflict of interest The authors declare no competing financial interest."

Evidence found in paper:

"We thank Professor Xuejie Yu (Wuhan University, China) for gifting the virus strain of SFTSV and Professor Jiahuai Han (Xiamen University, China) for providing the cDNA plasmid of p38α. This research was funded by the joint research fund of the National Science Fund of China—Science and Technology Development Fund of Macau SAR [No. 32161160303 for NSFC and 0010/2021/AFJ for FDCT], National Science Fund of China [No. 32070525], Innovative Research Groups of Hubei Natural Science Foundation [No. 2020CFA015], Fundamental Research Fund for the Central Universities of China [No. 2042021kf0219] and Open Research Fund Program of the State Key Laboratory of Virology of China [No. 2022KF004]."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025